Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Miikana Therapeutics Inc.

Division of CASI Pharmaceuticals Inc.

Latest From Miikana Therapeutics Inc.

Miikana Therapeutics Inc.

Miikana Therapeutics Inc. is focused on in-licensing late-stage oncology compounds that fit well with the staff's expertise in cancer pathways effecting apoptosis and mitotic catastrophe. Longer term, it will discover and develop drugs internally against novel but validated targets such as kinases, and histone deacetylases.

Start-Up Previews (1/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The Asthma Challenge: Not Solved Yet, features profiles of airPharma, Aperon Biosystems, Inverseon and Topigen Pharmaceuticals. Plus these Start-Ups across Health Care: Ensemble Discovery, Miikana Therapeutics, MiTiHeart and Resonant Medical.

Selected Start-Ups (11/03)

In Vivo briefly summarizes the technologies of these recently founded companies: ArthroSurface Inc., Biospect Inc., Collegium Pharmaceutical Inc., Magnetic BioSystems Inc., Miikana Therapeutics Inc. and Vesta Therapeutics Inc.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CASI Pharmaceuticals Inc.
  • Senior Management
  • Dinesh V Patel, PhD, Pres. & COO
    Tak W Mak, PhD, CSO
  • Contact Info
  • Miikana Therapeutics Inc.
    Phone: (510) 818-2751
    6519 Dumbarton Cir.
    Fremont, CA 94555